ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Pre-Tax Margin
Income before tax as a percentage of revenue.
No reported Pre-Tax Margin figures are available to summarize.
Pre-Tax Margin history
Percent of revenue · from the income statement
No Pre-Tax Margin data reported for this period type.
Pre-Tax Margin vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -151.1% | +333.8 pp | +673.9 pp | |
| LTM Mar 2026 | -173.5% | -122.7 pp | -103.0 pp | |
| LTM Mar 2026 | -255.7% | -148.7 pp | +3937.7 pp | |
| LTM Mar 2026 | -339.3% | -179.1 pp | +1518.7 pp | |
| FY2025 | -412.6% | — | — | |
| LTM Mar 2026 | -533.2% | -560.2 pp | +811.0 pp | |
| LTM Mar 2026 | -4917.6% | +338.4 pp | — | |
| LTM Mar 2026 | -9241.5% | — | -15620.7 pp | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ADRX) | -376.0% | -135.7 pp | +742.4 pp | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.